Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Detection Raises $1.9M to Support MRSA, Sepsis, GI Tests

NEW YORK (GenomeWeb News) – Molecular Detection today announced the completion of a $1.9 million Series B recapitalization round, which will be used to further advance its molecular diagnostic panel for methicillin-resistant Staphylococcus aureus and to develop panels for sepsis and gastrointestinal infections.

All existing investors participated in the round, including MentorTech Ventures, Robin Hood Ventures, Elm Spring Holdings, and the Mid-Atlantic Angel Group. Today's announcement is in addition to a $1.5 million financing that MDI announced in March to support development of the sepsis and GI test.

MDI's Detect-Ready MRSA Panel is for detecting MRSA and methicillin-sensitive S. aureus, and according to the Wayne, Penn.-based molecular diagnostic firm, it is the only marketed PCR-based MRSA screen that can differentiate these pathogens from other related bacteria. The test is CE-marked and available in the UK, Germany, Ireland, Switzerland, Spain, Austria, the Netherlands, Belgium, Luxembourg, Australia, and Israel. It is in late-stage development in the US, MDI said.

The Detect-Ready Sepsis and GI panels are expected to launch in the EU sometime this year.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.